Calmodulin activation of red blood cell (Ca2+ + Mg2+)-ATPase and its antagonism by phenothiazines.

B. Raess,F. Vincenzi

1980-09-01

Molecular Pharmacology

Abstract:Plasma membranes prepared from human red blood cells exhibit a Ca2+-activated, Mg2+-dependent adenosine triphosphatase activity which is a biochemical expression of the Ca2+ pump. The activity of this (Ca2++Mg2+-ATPase was increased severalfold by the Ca2+-binding protein, calmodulin, whether purified or present in a crude red blood cell hemolysate. The phenothiazines chlorpromazine (CPZ) and trifluoperazine (TFP) antagonized calmodulin activation of (Ca2++Mg2+-ATPase in an apparently competitive manner. CPZ and TFP were less effective in antagonizing (Ca2++Mg2+)-ATPase activity in the absence of added calmodulin. TFP antagonized the calmodulin-dependent portion of (Ca2++Mg2+)-ATPase activity relatively specifically at 10 and 30 µM. Up to 100 µM neither haloperidol nor d - or l-butaclamol significantly antagonized calmodulin-induced activation of the (Ca2++Mg2+-ATPase. Basal ATPase activity was also not inhibited. In contrast to the lack of inhibition by nonphenothiazine neuroleptics, ruthenium red nonspecifically antagonized both basal and calmodulin-activated (Ca2++Mg2+)-ATPase activity. It was concluded that phenothiazines antagonize activation of the (Ca2++Mg2+)-ATPase by binding to calmodulin. Ruthenium red appears to have a different mechanism of action. Because the potent neuroleptic nonphenothiazines, haloperidol and butaclamol, fail to antagonize calmodulin activation of red blood cell (Ca2++Mg2+-ATPase it appears that general anti-calmodulin activity does not correlate with neuroleptic activity.